Table 1 Lead SNPs near SP4, 8q24, and IKZF3 reaching genome-wide significance in discovery analyses of CCRLP acute lymphoblastic leukemia patients, including replication analyses in the Children’s Oncology Group and the California Childhood Leukemia Study Latino Participants
SP4—rs2390536 risk allele Aa | 8q24.1—rs4617118 risk allele Gb | IKZF3—rs2290400 risk allele Tc | |||||||
|---|---|---|---|---|---|---|---|---|---|
RAFd | P value | OR (95% CI) | RAFa | P value | OR (95% CI) | RAFa | P value | OR (95% CI) | |
CCRLP meta-analysise | 3.59 × 10 −8 | 1.20 (1.13–1.29) | 3.05 × 10 −9 | 1.27 (1.17–1.38) | 2.05 × 10 −8 | 1.18 (1.11–1.25) | |||
CCRLP Latinos | 0.26 | 1.42 × 10−4 | 1.19 (1.09–1.31) | 0.15 | 2.90 × 10−5 | 1.25 (1.12–1.38) | 0.57 | 4.33 × 10−6 | 1.20 (1.11–1.30) |
CCRLP Whites | 0.35 | 5.69 × 10−5 | 1.23 (1.11–1.35) | 0.18 | 1.74 × 10−3 | 1.26 (1.09–1.45) | 0.50 | 2.72 × 10−3 | 1.15 (1.05–1.26) |
CCRLP African Americans | 0.22 | 0.73 | 1.07 (0.73–1.58) | 0.23 | 1.55 × 10−3 | 1.54 (1.18–2.01) | 0.52 | 0.18 | 1.19 (0.92–1.53) |
Replication meta-analysis | 0.075 | 1.10 (0.99–1.23) | 1.29 × 10 −4 | 1.30 (1.14–1.49) | 0.013 | 1.14 (1.03–1.26) | |||
COG Replication (European) | 0.36 | 0.025 | 1.15 (1.018–1.31) | 0.17 | 0.011 | 1.22 (1.05–1.43) | 0.45 | 0.13 | 1.10 (0.97–1.25) |
CCLS Replication (Hispanic) | 0.2133 | 0.74 | 0.96 (0.77–1.20) | 0.1069 | 1.03 × 10−3 | 1.58 (1.20–2.07) | 0.6135 | 0.030 | 1.22 (1.02–1.46) |
Combined datasets | 1.77 × 10 −8 | 1.18 (1.11–1.24) | 1.76 × 10 −12 | 1.28 (1.19–1.37) | 1.06 × 10 −9 | 1.17 (1.11–1.23) | |||